Toward clinical applications of carotid ultrasound: Intima-media thickness, plaque area, and three-dimensional phenotypes

Ultrasound and Carotid Bifurcation Atherosclerosis

Volumn 9781848826885, Issue , 2012, Pages 431-448

  Spence, J David ^a   Rundek, Tatjana ^b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930030967     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-688-5_25     Document Type: Chapter

References (107)

1. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation. 2002;106(13): 1602-1605.
2. D'Agostino RB Sr et al. General cardiovascular risk profile for use in primary care: the Framingham Heart study. Circulation. 2008;117(6): 743-753.
3. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118(22): 2243-2251, 4p.
4. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105(3): 310-315.
5. De BG et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1-S10.
6. D'Agostino RB Sr et al. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) General cardiovascular risk profile for use in primary care: the Framingham Heart study. JAMA. 2001;285(19): 2486-2497.
7. Hippisley-Cox J et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336(7659): 1475-1482.
8. Alexopoulos N, Raggi P. Calcification in atherosclerosis. Nat Rev Cardiol. 2009;6(11): 681-688.
9. Romanens M et al. Imaging as a cardiovascular risk modifier in primary care patients using predictor models of the European and international atherosclerosis societies. Kardiovaskuläre Medizin. 2007;10: 139-150.
10. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22): 1371-1375.
11. Spence JD. Advances in atherosclerosis: new understanding based on endothelial function. In: Fisher M, Bogousslavsky J, eds. Current Review of Cerebrovascular Disease. 3rd ed. Philadelphia: Current Medicine; 1999: 1-13.
12. Spence JD. The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions. Can J Cardiol. 2010;26: 37A-40A.
13. Touboul PJ et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18(4): 346-349.
14. Adams MR et al. Carotid intimal-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995;92: 2127-2134.
15. Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol. 2007;27(5): 986-989.
16. Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(11): e188-e189.
17. Al Shali K et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis. 2005;178(2): 319-325.
18. Kolodgie FD et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349(24): 2316-2325.
19. Spence JD, Norris J. Infection, inflammation, and atherosclerosis. Stroke. 2003;34(2): 333-334.
20. Kolodgie FD et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26(11): 2523-2529.
21. Virmani R et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25(10): 2054-2061.
22. Feric NT, Boffa MB, Johnston SM, Koschinsky ML. Apolipoprotein( a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation. J Thromb Haemost. 2008;6(12): 2113-2120.
23. Klein JH et al. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arterioscler Thromb Vasc Biol. 2008;28: 1851-1856.
24. O'Leary DH et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke. 1996;27(2): 224-231.
25. Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke. 2004;35: 649-653.
26. Finn AV, Kolodgie FD, Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol. 2010;30(2): 177-181.
27. Clarkson TB, Bond MG, Bullock BC, McLaughlin KJ, Sawyer JK. A study of atherosclerosis regression in Macaca mulatta. V. Changes in abdominal aorta and carotid and coronary arteries from animals with atherosclerosis induced for 38 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp Mol Pathol. 1984;41(1): 96-118.
28. Bond MG, Wilmoth SK, Gardin JF, Barnes RW, Sawyer JK. Noninvasive assessment of atherosclerosis in nonhuman primates. Adv Exp Med Biol. 1985;183: 189-195.
29. Bond MG, Wilmoth SK, Enevold GL, Strickland HL. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med. 1989;86(4A): 33-36.
30. Baldassarre D et al. Measurement of carotid artery intimamedia thickness in dyslipidemic patients increases the power of traditional risk factors to predict cardiovascular events. Atherosclerosis. 2007;191(2): 403-408.
31. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96(5): 1432-1437.
32. O'Leary DH et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340: 14-22.
33. Chambless LE et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;151 (5): 478-487.
34. Ebrahim S et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart study. Stroke. 1999;30(4): 841-850.
35. Lorenz MW, von Kegler J, Steinmetz H, Markus H, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37: 87-92.
36. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol. 2009;30(2): 182-185.
37. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and metaanalysis. Circulation. 2007;115: 459-467.
38. Bots ML et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J. 2007;28(4): 398-406.
39. Prati P et al. Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke. 2008;39(9): 2470-2476.
40. Brook RD et al. A negative carotid plaque area test is superior to other non-invasive atherosclerosis studies for reducing the likelihood of having significant coronary artery disease. Arterioscler Thromb Vasc Biol. 2006;26: 656-662.
41. Chan SY et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol. 2003;42 (6): 1037-1043.
42. Rundek T et al. Carotid plaque, a subclinical precursorof vascular events: the Northern Manhattan study. Neurology. 2008;70: 1200-1207.
43. Barnett PA, Spence JD, Manuck SB, Jennings JR. Psychological stress and the progression of carotid artery disease. J Hypertens. 1997;15(1): 49-55.
44. Persson J et al. Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. Arterioscler Thromb. 1992;12(2): 261-266.
45. Mancini GB, Abbott D, Kamimura C, Yeoh E. Validation of a new ultrasound method for the measurement of carotid artery intima medial thickness and plaque dimensions. Can J Cardiol. 2004;20(13): 1355-1359.
46. Fosse E et al. Repeated visual and computer-assisted carotid plaque characterization in a longitudinal population-based ultrasound study: the Tromso study. Ultrasound Med Biol. 2006;32(1): 3-11.
47. Spence JD et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33: 2916-2922.
48. Johnsen SH et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso study. Stroke. 2007;38(11): 2873-2880.
49. Ainsworth CD et al. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke. 2005;36(9): 1904-1909.
50. Egger M, Spence JD, Fenster A, Parraga G. Validation of 3D ultrasound vessel wall volume: an imaging phenotype of carotid atherosclerosis. Ultrasound Med Biol. 2007;33(6): 905-914.
51. Kuller L et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health study. Am J Epidemiol. 1994;139(12): 1164-1179.
52. Sharrett AR et al. Smoking, diabetes and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2005;186: 441-447.
53. Heiss G et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in theARIC study. AmJ Epidemiol. 1991;134(3): 250-256.
54. Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis. 1988;8(6): 788-792.
55. Fine-Edelstein JS et al. Precursors of extracranial carotid atherosclerosis in the Framingham study. Neurology. 1994;44(6): 1046-1050.
56. Polak JF et al. Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Stroke. 2010;41(1): 9-15.
57. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities study. Circulation. 1993;87 (4): 1107-1113.
58. Rundek T et al. The metabolic syndrome and subclinical carotid atherosclerosis: the northern Manhattan study. J Cardiometab Syndr. 2007;2(1): 24-29.
59. Elkind MS et al. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis. 2005;180(1): 181-187.
60. Melnick SL et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) study investigators. Am J Med. 1993;5: 499-504.
61. Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 2009;11(1): 21-27.
62. Spence JD et al. Plasma homocyst(e)ine, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke. 1999;30: 969-973.
63. Hegele RA, Ban MR, Anderson CM, Spence JD. Infectionsusceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med. 2003;48: 198-202.
64. Nilsson TK et al. Quantitative measurement of carotid atherosclerosis in relation to levels of von Willebrand factor and fibrinolytic variables in plasma - a 2-year follow-up study. J Cardiovasc Risk. 2002;9(4): 215-221.
65. Bhavsar S et al. Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis. Clin Invest Med. 2009;32(2):E95-E102.
66. Kronborg J et al. Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromso study. Diabetologia. 2007;50(8): 1607-1614.
67. Johnsen SH et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study. Circulation. 2005;112(4): 498-504.
68. Halvorsen DS, Johnsen SH, Mathiesen EB, Njolstad I. The association between inflammatory markers and carotid atherosclerosis is sex dependent: the Tromso study. Cerebrovasc Dis. 2009;27(4): 392-397.
69. Pollex RL et al. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound. 2005;3: 15.
70. Lange LA et al. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke. 2002;33(7): 1876-1881.
71. Juo SH et al. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family study. Stroke. 2004;35(10): 2243-2247.
72. Xiang AH et al. Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler Thromb Vasc Biol. 2002;22(5): 843-848.
73. Fox CS et al. Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart study. Stroke. 2003;34(2): 397-401.
74. Chen YC et al. Carotid intima-media thickness (cIMT) cosegregates with blood pressure and renal function in hypertensive Hispanic families. Atherosclerosis. 2008;198(1): 160-165.
75. Manolio TA, Boerwinkle E, O'Donnell CJ, Wilson AF. Genetics of ultrasonographic carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(9): 1567-1577.
76. Rundek T et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort study. Stroke. 2002;33 (5): 1420-1423.
77. O'Donnell CJ et al. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart study. BMC Med Genet. 2007;8(suppl 1):S4.
78. Fox CS et al. Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet. 2004;74(2): 253-261.
79. Wang D et al. A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke. 2005;36(3): 540-545.
80. Sacco RL et al. Heritability and linkage analysis for carotid intima-media thickness: the family study of stroke risk and carotid atherosclerosis. Stroke. 2009;40(7): 2307-2312.
81. Pollex RL, Hegele R. Genetic determinants of carotid ultrasound traits. Curr Atheroscler Rep. 2006;8(3): 206-215.
82. Yasuda H et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension. J Hum Hypertens. 2007;21(11): 883-892.
83. Lehtinen AB et al. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab. 2007;92(1): 345-352.
84. Pankow JS et al. Familial aggregation and genome-wide linkage analysis of carotid artery plaque: the NHLBI family heart study. Hum Hered. 2004;57(2): 80-89.
85. Spence JD, Ban MR, Hegele RA. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque. Stroke. 2003;34: 1178-1182.
86. Spence JD, Barnett PA, Bulman DE, Hegele RA. An approach to ascertain probands with a non traditional risk factor for carotid atherosclerosis. Atherosclerosis. 1999;144: 429-434.
87. Spence JD. Technology Insight: ultrasound measurement of carotid plaque - patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;2(11): 611-619.
88. Schork NJ, Nath SK, Fallin D, Chakravarti A. Linkage disequilibrium analysis of biallelic DNA markers, human. Am J Hum Genet. 2000;67(5): 1208-1218.
89. Malo N, Libiger O, Schork NJ. Accommodating linkage disequilibrium in genetic-association analyses via ridge regression. Am J Hum Genet. 2008;82(2): 375-385.
90. Al Shali KZ et al. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke. 2004;35(9): 2036-2040.
91. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke. 2003;34 (12): 2985-2994.
92. Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 mol/L. Am J Hypertens. 2000;13: 105-110.
93. Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G. Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis. Ultrasound Med Biol. 2009;35: 1763-1772.
94. Hegele RA et al. Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Stroke. 2005;36(12): 2566-2570.
95. Cao H et al. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004;89(2): 898-903.
96. Pollex RL, Hegele RA. Genetic determinants of carotid ultrasound traits. Curr Atheroscler Rep. 2006;8: 206-215.
97. Wang JG et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke. 2006;37(7): 1933-1940.
98. Zanchetti Aet al. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation. 2009;120(12): 1084-1090.
99. Peterson JC, Spence JD. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia [letter]. Lancet. 1998;351(9098): 263.
100. Ranke C, Hecker H, Creutzig A, Alexander K. Dosedependent effect of aspirin on carotid atherosclerosis. Circulation. 1993;87: 1873-1879.
101. Kastelein JJ et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358(14): 1431-1443.
102. Taylor AJ et al. Extended-release niacin or ezetimibe and carotid intima-media thickness.NEngl JMed. 2009;361(22): 2113-2122.
103. Spence JD. Is carotid intima-media thickness a reliable clinical predictor? Mayo Clin Proc. 2008;83(11): 1299-1300.
104. Spence JD. The importance of distinguishing between diffuse carotid intima medial thickening and focal plaque. Can J Cardiol. 2008;24(suppl C): 61C-64C.
105. Spence JD, Hackam DG. Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke. 2010;41(6): 1193-1199.
106. Spence JD et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67(2): 180-186.
107. Spence JD. Adding ezetimibe to statin halts progression of carotid plaque. Basic Clin Pharmacol Toxicol. 2010;107 (suppl 1): 2194.